Special Interest Projects

Special Interest Projects (SIPs) are funded by the CDC in specific project areas and are only available to Prevention Research Centers. The following are HPRC’s current SIPs.

Multi-year projects in progress:

Healthy Brain Research Network (HBRN)  PI: Basia Belza
HPRC is the Coordinating Center of this six-member network focused on establishing a public health research/translation agenda for cognitive health and healthy aging. Along with initiating an HBRN Scholars Program, the network has launched a multi-site focus group project: Testing Media Messages for Adult Children with Concerns about their Aging Parents. The network is also conducting a systematic review of cognitive aging and impairment terminology, and consulting with the Alzheimer’s Association on state public health agencies’ toolkits.

Managing Epilepsy Well Network (MEW)  PI: Robert Fraser
The goal of the MEW network is to advance the science related to epilepsy self-management by conducting research with network and community stakeholders, implementing programs with partners, and broadly distributing research findings. The HPRC MEW member center is focused on validating and extending an epilepsy self-management program (PACES) tailored to the needs of community-dwelling adults, including U.S. veterans.

Alliance for Reducing Cancer Northwest (ARC NW)  PI: Peggy Hannon
As part of the CDC’s Cancer Prevention and Control Research Network (CPCRN) ARC NW conducts translational research related to healthcare and workplace settings. ARC NW is participating in multi-center projects to: increase HPV vaccination, increase colorectal cancer screening in Federally Qualified Health Centers, and lead and co-author collaborative manuscripts.

BeneFIT  PI: Laura-Mae Baldwin
This project is a collaboration with two Medicaid/Medicare health plans to develop, conduct, and evaluate a health plan-level, direct-mail fecal immunochemical test program for colorectal cancer screening.

Economic Costs of Quality Assurance in Lung Cancer Screening Programs  
PI: Steve Zeliadt

Working with community lung cancer screening programs, this project seeks to develop practical approaches for monitoring the quality and performance of lung cancer screening to ensure the potential benefits of screening are maximized and harms are minimized.

Progestins and HIV Risk  PIs: Jared Baeten and Jairam Lingappa
Because some studies suggest women using progestin-based injectable contraceptive methods may have an enhanced HIV-1 risk, this study will use a repository of data and biologic samples to understand the effect of progestin-based contraception on HIV-1 transmission and disease.

HPV Vaccine Impact among Men who have Sex with Men  PI: Rachel Winer
This cross-sectional study is designed to determine real-world impact of human papillomavirus (HPV) vaccination on HPV prevalence in young men who have sex with men.

New SIPs awarded in 2016:

Evaluating the Adoption and Implementation of an Evidence-Based Patient Navigation Intervention for Colonoscopy Screening  PIs: Allison Cole and Peggy Hannon
The New Hampshire Colorectal Cancer Screening Control Program Patient Navigation intervention has been shown to be effective in increasing colonoscopy completion and reducing appointment cancellations and no-shows among low income, un/underinsured patients. This project will determine whether replication of this intervention by other Colorectal Cancer Control Program grantees can achieve similar results. If so, further dissemination and scale-up of the intervention could improve colonoscopy screening rates in other states/settings.

Promoting Humanpapilloma Virus (HPV) Vaccination in Washington’s East African Communities  PI: Rachel Winer
This project aims to develop and test multi-level health communication strategies to promote HPV vaccination in underserved or high-risk populations. The project will develop and test HPV communication messages that are sensitive to cultural, literacy/health literacy, and language differences, access issues, and/or lack of trust in health care systems among the target population due to experienced bias, discrimination, or other factors. There is potential to increase HPV vaccine uptake in communities where vaccination rates lag behind national goals.